Item 9 Labs Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
For the six months, sales was USD 12.82 million compared to USD 9.15 million a year ago. Net loss was USD 7.22 million compared to USD 1.03 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.02 a year ago.